| scholarly article | Q13442814 |
| P2093 | author name string | M C Mihm | |
| D F Roses | |||
| A B Cosimi | |||
| M N Harris | |||
| R A Malt | |||
| A W Kopf | |||
| R J Friedman | |||
| W C Wood | |||
| R A Lew | |||
| A J Sober | |||
| S L Gumport | |||
| T B Fitzpatrick | |||
| A Postel | |||
| C L Day | |||
| D Rigel | |||
| F Gorstein | |||
| F M Golomb | |||
| J W Raker | |||
| M M Mintzis | |||
| P Hennessey | |||
| T J Harrist | |||
| P2860 | cites work | A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease | Q70743908 |
| Malignant melanoma patients with positive nodes and relatively good prognoses: Microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes | Q70755933 | ||
| Is malignant melanoma arising in a Hutchinson's melanotic freckle a separate disease entity? | Q71240108 | ||
| PROGNOSIS IN MALIGNANT MELANOMA | Q76973266 | ||
| MALIGNANT MELANOMA: A CLINICAL STUDY OF 427 CASES | Q78419634 | ||
| Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma | Q24540048 | ||
| The histogenesis and biologic behavior of primary human malignant melanomas of the skin | Q34054176 | ||
| A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma | Q41711591 | ||
| The regressing thin malignant melanoma: a distinctive lesion with metastatic potential | Q43877987 | ||
| The prognostic significance of ulceration of cutaneous melanoma | Q44362550 | ||
| Prognostic factors in cutaneous malignant melanoma in stage I. A clinical, morphological and multivariate analysis | Q44397348 | ||
| A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models | Q44799666 | ||
| Curability of melanoma: a 25-year retrospective study | Q47357969 | ||
| Inefficacy of immediate node dissection in stage 1 melanoma of the limbs | Q50986397 | ||
| A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods | Q52437315 | ||
| The Natural Break Points for Primary-Tumor Thickness in Clinical Stage I Melanoma | Q52732552 | ||
| A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease. | Q52735595 | ||
| Prognosis in malignant melanoma. | Q52753863 | ||
| Malignant melanoma of the extremities: A clinicopathologic study using levels of invasion (microstage) | Q66908743 | ||
| Stage I melanoma of the limbs. Immediate versus delayed node dissection | Q67250734 | ||
| Prognostic index in malignant melanoma | Q67349831 | ||
| Stage I melanoma of the limbs: assessment of prognosis by levels of invasion and maximum thickness | Q67362199 | ||
| Melanoma of the trunk: the results of surgical excision and anatomic guidelines for predicting nodal metastasis | Q67788387 | ||
| Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions | Q70269701 | ||
| A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II) | Q70717837 | ||
| A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease | Q70717847 | ||
| Surgical management of regional lymph nodes in cutaneous melanoma | Q70730854 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 35-43 | |
| P577 | publication date | 1982-01-01 | |
| P1433 | published in | Annals of Surgery | Q4767866 |
| P1476 | title | Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. | |
| P478 | volume | 195 |
| Q70535936 | A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia |
| Q44799666 | A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models |
| Q70299689 | An evaluation of vertical growth in thin superficial spreading melanomas by sequential serial microscopic sections |
| Q47597950 | Angiotropism is an independent predictor of microscopic satellites in primary cutaneous melanoma |
| Q49718299 | Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehe |
| Q36134266 | Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group |
| Q39736224 | Cutaneous malignant melanoma in the older patient. |
| Q40717524 | Elective lymph node dissection for melanoma |
| Q72269062 | Expression of the p53 protein in malignant melanomas as a prognostic indicator |
| Q72528647 | Failure of FAB classification to predict relapse-free survival in acute leukemia |
| Q40189858 | Human malignant melanoma |
| Q39477930 | Immunology and immunotherapy of human malignant melanoma. |
| Q36421679 | Intraoperative identification of sentinel lymph node in patients with malignant melanoma |
| Q77797513 | Malignant melanoma |
| Q34040845 | Malignant melanoma and the sentinel lymph node biopsy |
| Q52871928 | Malignant melanoma prognostic factors 7: elective lymph node dissection. |
| Q44972174 | Management of cutaneous melanoma M0: state of the art and trends |
| Q35993091 | Management of the regional lymph nodes in patients with cutaneous malignant melanoma |
| Q73293803 | Melanoma antigen recognition by tumour-infiltrating T lymphocytes (TIL): effect of differential expression of melan-A/MART-1 |
| Q72231493 | Melanoma recurrence surveillance. Patient or physician based? |
| Q73624324 | Mohs micrographic surgery for the treatment of primary cutaneous melanoma |
| Q71931085 | Pathology of malignant melanoma |
| Q71767718 | Predictors of late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosis |
| Q41520554 | Prognostic Factors in Malignant Melanoma |
| Q52568001 | Prognostic Significance of DNA Aneuploidy in Stage I Cutaneous Melanoma |
| Q70269701 | Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions |
| Q35105671 | Prognostic factors in primary cutaneous melanoma |
| Q67945545 | Prognostic significance of melanoma arising in the scalp |
| Q36381934 | Prognosticators of melanoma, the melanoma report, and the sentinel lymph node |
| Q71688574 | Regression in malignant melanoma |
| Q36704680 | Review of general surgery 1982. |
| Q72528649 | Subsite concept for metastases in clinical stage I melanoma |
| Q69948186 | Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. A multivariate regression analysis |
| Q69716172 | The Ki-67 antigen in primary human melanomas--its relationship to mitotic rate and tumor thickness and its stability |
| Q39726052 | The clinical recognition and prognostic factors of primary cutaneous malignant melanoma |
| Q40233231 | The extent of primary melanoma excision. A re-evaluation--how wide is wide? |
| Q33828587 | The pathologist's role in sentinel lymph node evaluation |
| Q35819050 | The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study |
| Q68076715 | The significance of inflammation and regression in melanoma |
| Q69976925 | Therapeutic and clinico-pathological factors in the survival of 1,469 patients with primary cutaneous malignant melanoma in clinical stage I. A multivariate regression analysis |
| Q74635542 | Thin cutaneous malignant melanomas (< or =1.5 mm): identification of risk factors indicative of progression |
| Q40975458 | Thin melanomas with unusual aggressive behavior: a report on nine cases. Melanoma Group of French Federation of Cancer Centers |
| Q38470823 | Tumor-associated antigen TA-90 immune complex assay predicts subclinical metastasis and survival for patients with early stage melanoma |
| Q80721187 | [Protocol proposal for the histological report of the primary tumor in patients with cutaneous melanoma from the Task Force for Cutaneous Melanoma of the Valencian Community] |
Search more.